Cooperative effects of genes controlling the G(2)/M checkpoint.

T A Chan, P M Hwang, H Hermeking, K W Kinzler, B Vogelstein
Author Information
  1. T A Chan: Howard Hughes Medical Institute and Johns Hopkins Oncology Center, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.

Abstract

It is believed that multiple effectors independently control the checkpoints permitting transitions between cell cycle phases. However, this has not been rigorously demonstrated in mammalian cells. The p53-induced genes p21 and 14-3-3sigma are each required for the G(2) arrest and allow a specific test of this fundamental tenet. We generated human cells deficient in both p21 and 14-3-3sigma and determined whether the double knockout was more sensitive to DNA damage than either single knockout. p21(-/-) 14-3-3sigma(-/-) cells were significantly more sensitive to DNA damage or to the exogenous expression of p53 than cells lacking only p21 or only 14-3-3sigma. Thus, p21 and 14-3-3sigma play distinct but complementary roles in the G(2)/M checkpoint, and help explain why genes at the nodal points of growth arrest pathways, like p53, are the targets of mutation in cancer cells.

References

  1. Cell. 1993 Aug 13;74(3):463-74 [PMID: 8348613]
  2. Nature. 1999 Oct 7;401(6753):616-20 [PMID: 10524633]
  3. Cell. 1993 Nov 19;75(4):805-16 [PMID: 8242751]
  4. Cell. 1993 Nov 19;75(4):817-25 [PMID: 8242752]
  5. Nature. 1993 Dec 16;366(6456):701-4 [PMID: 8259214]
  6. Cancer Res. 1994 Mar 1;54(5):1169-74 [PMID: 8118801]
  7. Oncogene. 1994 Jun;9(6):1767-73 [PMID: 8183575]
  8. Oncogene. 1994 Jun;9(6):1799-805 [PMID: 8183579]
  9. Semin Cancer Biol. 1994 Jun;5(3):221-7 [PMID: 7948950]
  10. Oncogene. 1995 Jan 5;10(1):109-15 [PMID: 7529916]
  11. Genetics. 1994 Oct;138(2):271-81 [PMID: 7828811]
  12. Cell. 1995 Aug 25;82(4):675-84 [PMID: 7664346]
  13. Proc Natl Acad Sci U S A. 1995 Aug 29;92(18):8493-7 [PMID: 7667317]
  14. Nature. 1995 Oct 12;377(6549):552-7 [PMID: 7566157]
  15. Cancer Res. 1995 Nov 15;55(22):5187-90 [PMID: 7585571]
  16. Nature. 1996 Jun 20;381(6584):713-6 [PMID: 8649519]
  17. Genes Dev. 1996 Aug 1;10(15):1945-52 [PMID: 8756351]
  18. Cell. 1997 Feb 7;88(3):323-31 [PMID: 9039259]
  19. Nat Med. 1997 Sep;3(9):1034-6 [PMID: 9288734]
  20. Nature. 1997 Sep 18;389(6648):300-5 [PMID: 9305847]
  21. Nature. 1998 Mar 19;392(6673):300-3 [PMID: 9521327]
  22. Mol Cell. 1997 Dec;1(1):3-11 [PMID: 9659898]
  23. Science. 1998 Nov 20;282(5393):1497-501 [PMID: 9822382]
  24. J Clin Invest. 1999 Aug;104(3):263-9 [PMID: 10430607]
  25. Proc Natl Acad Sci U S A. 1999 Dec 7;96(25):14517-22 [PMID: 10588737]
  26. Science. 1991 Jul 5;253(5015):49-53 [PMID: 1905840]
  27. Nature. 1991 Jul 25;352(6333):345-7 [PMID: 1852210]
  28. Proc Natl Acad Sci U S A. 1992 May 15;89(10):4495-9 [PMID: 1584781]
  29. Hosp Pract (Off Ed). 1992 Nov 15;27(11):51-8 [PMID: 1331139]
  30. Radiat Res. 1992 Nov;132(2):141-3 [PMID: 1438694]
  31. Cancer Res. 1993 Sep 15;53(18):4164-8 [PMID: 8364909]

Grants

  1. CA57345/NCI NIH HHS
  2. P50 CA062924/NCI NIH HHS
  3. CA62924/NCI NIH HHS
  4. R37 CA057345/NCI NIH HHS
  5. R01 CA057345/NCI NIH HHS

MeSH Term

14-3-3 Proteins
Cell Line
Cyclin-Dependent Kinase Inhibitor p21
Cyclins
DNA Damage
G2 Phase
Gene Deletion
Humans
Mitosis
Proteins
Tumor Suppressor Protein p53
Tyrosine 3-Monooxygenase

Chemicals

14-3-3 Proteins
CDKN1A protein, human
Cyclin-Dependent Kinase Inhibitor p21
Cyclins
Proteins
Tumor Suppressor Protein p53
Tyrosine 3-Monooxygenase

Word Cloud

Created with Highcharts 10.0.0cellsp2114-3-3sigmagenesG2arrestknockoutsensitiveDNAdamage-/-p53/McheckpointbelievedmultipleeffectorsindependentlycontrolcheckpointspermittingtransitionscellcyclephasesHoweverrigorouslydemonstratedmammalianp53-inducedrequiredallowspecifictestfundamentaltenetgeneratedhumandeficientdeterminedwhetherdoubleeithersinglesignificantlyexogenousexpressionlackingThusplaydistinctcomplementaryroleshelpexplainnodalpointsgrowthpathwaysliketargetsmutationcancerCooperativeeffectscontrolling

Similar Articles

Cited By